Meeting
2021 ASCO Annual Meeting
Real-world survival outcomes associated with completion of adjuvant chemotherapy for stage III colon cancer.
Authors
Jemma Megan Boyle
London School of Hygiene and Tropical Medicine, London, United Kingdom
Jemma Megan Boyle , Angela Kuryba , Thomas E Cowling , Jan van der Meulen , Nicola S Fearnhead , Kate Walker , Michael Braun , Ajay Aggarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer - Neo-Adjuvant/Adjuvant
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3596)
DOI
10.1200/JCO.2021.39.15_suppl.3596
Abstract #
3596
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Survival and patient-reported outcomes of real-world patients with high-risk stage II and stage III colon cancer after 3 versus 6 months of adjuvant CAPOX.
First Author: Ingrid A. Franken
Poster
2022 ASCO Annual Meeting
Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis.
First Author: Romain Cohen
Poster
2021 ASCO Quality Care Symposium
Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer.
First Author: Jennifer Leigh Lund
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah